Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.12B |
| 2 |
ExxonMobil
XOM
|
+$884M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$856M |
| 4 |
American International
AIG
|
+$594M |
| 5 |
Crown Castle
CCI
|
+$542M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
Gilead Sciences
GILD
|
+$1.23B |
| 3 |
DuPont de Nemours
DD
|
+$982M |
| 4 |
General Motors
GM
|
+$683M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.83% |
| 2 | Technology | 12.2% |
| 3 | Industrials | 11.56% |
| 4 | Communication Services | 11.27% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Medtronic
MDT
$116B
| $25.8M | 0.01% |
450,000
| – | – |
|
|
LEAF
352
DELISTED
Leaf Group Ltd.
LEAF
| $25.5M | 0.01% |
2,224,938
-463,680
| -17% | -$4.99M |
|
353
OneMain Financial
OMF
$7.44B
| $25.3M | 0.01% |
+1,000,000
| New | +$21.4M |
|
|
ABCO
354
DELISTED
Advisory Board Co
ABCO
| $24.8M | 0.01% |
390,000
| – | – |
|
355
Royal Caribbean
RCL
$82.4B
| $23.7M | 0.01% |
500,000
| – | – |
|
|
TA
356
DELISTED
TravelCenters of America LLC
TA
| $23.6M | 0.01% |
484,750
+88,500
| +22% | +$4.06M |
|
357
Boyd Gaming
BYD
$6.03B
| $23.1M | 0.01% |
2,049,000
| – | – |
|
|
IPHI
358
DELISTED
INPHI CORPORATION
IPHI
| $22.9M | 0.01% |
1,774,299
+584,336
| +49% | +$7.48M |
|
359
Oxford Industries
OXM
$538M
| $21.8M | 0.01% |
+270,268
| New | +$19.7M |
|
360
Cognex
CGNX
$10.2B
| $21M | 0.01% |
1,102,404
-100,000
| -8% | -$1.62M |
|
|
SCAI
361
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $21M | 0.01% |
+603,000
| New | +$18.4M |
|
362
Semtech
SMTC
$13B
| $20.5M | 0.01% |
811,000
| – | – |
|
363
CONMED
CNMD
$1.48B
| $20.2M | 0.01% |
475,000
| – | – |
|
364
CEMIG Preferred Shares
CIG
$5.61B
| $19.9M | 0.01% |
6,549,957
-9,987,783
| -60% | -$33.1M |
|
365
Ovintiv
OVV
$17.5B
| $19.7M | 0.01% |
218,000
| – | – |
|
|
BLT
366
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $19.5M | 0.01% |
1,350,500
-1,725,000
| -56% | -$22.9M |
|
367
Comstock Resources
CRK
$4.09B
| $19.4M | 0.01% |
212,122
-292,900
| -58% | -$25.4M |
|
|
SGI
368
DELISTED
Silicon Graphics Intl.
SGI
| $18.2M | 0.01% |
1,355,000
+969,948
| +252% | +$13.1M |
|
369
Comfort Systems
FIX
$61.2B
| $17.1M | 0.01% |
879,707
-1,596,293
| -64% | -$30.2M |
|
370
CDW
CDW
$17.1B
| $16.4M | 0.01% |
700,000
| – | – |
|
371
Clearway Energy Class C
CWEN
$7.06B
| $16.1M | 0.01% |
806,914
-393,086
| -33% | -$7.01M |
|
|
PLG
372
Platinum Group Metals
PLG
$196M
| $16.1M | 0.01% |
+134,750
| New | +$15.8M |
|
373
Sprouts Farmers Market
SFM
$8.03B
| $15.9M | 0.01% |
414,900
-85,100
| -17% | -$3.6M |
|
374
MACOM Technology Solutions
MTSI
$23.7B
| $15.9M | 0.01% |
935,000
| – | – |
|
|
RFMD
375
DELISTED
RF MICRO DEVICES INC
RFMD
| $15.7M | 0.01% |
3,045,000
+393,000
| +15% | +$2.11M |
|
Similar funds
Capital Research Global Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Capital Research Global Investors held 473 positions worth $270B, up 6.6% from $253B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors withdrew a net $8.14B in Q4 2013, closing 44 positions and reducing 142 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $664M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Capital Research Global Investors opened a new position in American International worth $608M.
- Capital Research Global Investors's largest Q4 2013 buy was American International: 11,917,900 shares worth $608M.
- Capital Research Global Investors added most to Amgen in Q4 2013, an estimated $1.12B increase.
- Capital Research Global Investors's biggest Q4 2013 reduction was Microsoft, cutting an estimated $2.44B.
- Capital Research Global Investors fully exited FOREST LABORATORIES INC in Q4 2013, selling an estimated $664M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $270B portfolio in Q4 2013.
- Capital Research Global Investors opened 27 new positions and closed 44 in Q4 2013.
- Capital Research Global Investors's portfolio value rose 6.6% quarter-over-quarter to $270B.
Based on Capital Research Global Investors's 13F filing for Q4 2013, filed 14 Feb 2014.